Benzinga | May 4, 2021 04:00PM EDT

Exact Sciences Q1 EPS $(0.18) Beats $(1.03) Estimate, Sales $402.10M Beat $388.57M Estimate

Exact Sciences (NASDAQ:EXAS) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(1.03) by 82.52 percent. This is a 72.73 percent increase over losses of $(0.66) per share from the same period last year. The company reported quarterly sales of $402.10 million which beat the analyst consensus estimate of $388.57 million by 3.48 percent. This is a 15.61 percent increase over sales of $347.82 million the same period last year.